Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Down 27%: Impax Labs' Massive Drop
Motley Fool
Wednesday, March 6, 2013 - 9:56am
tags:
Impax Laboratories
Can Anything Stop Johnson & Johnson?
Motley Fool
Wednesday, March 6, 2013 - 9:56am
tags:
JNJ
Taking A Close Look At Bristol-Myers' Dividend
Seeking Alpha
Wednesday, March 6, 2013 - 9:55am
tags:
Bristol-Myers Squibb
4 Healthcare Stock Stories for Tuesday Investment Wellness
Wall Street Cheat Street
Wednesday, March 6, 2013 - 9:54am
tags:
JNJ, AcelRx, Herbalife, Santarus
Pfizer painkiller gets longer patent protection
Yahoo/AP
Wednesday, March 6, 2013 - 9:52am
tags:
Pfizer, Celebrex
The Dow's Best Health Care Stock: Pfizer
Motley Fool
Wednesday, March 6, 2013 - 9:51am
tags:
Pfizer
Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players
Motley Fool
Wednesday, March 6, 2013 - 9:49am
tags:
prostate cancer, Zytiga, JNJ, Xtandi, Medivation, Astellas, Provenge, Dendreon, Jevtana, Sanofi
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
Yahoo/MarketWire
Wednesday, March 6, 2013 - 9:47am
tags:
Osiris Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results
Yahoo/BusinessWire
Wednesday, March 6, 2013 - 9:47am
tags:
Osiris Therapeutics, earnings
Royalty Pharma Meeting With Elan Investors on Bid
Bloomberg
Wednesday, March 6, 2013 - 9:46am
tags:
Royalty Pharma, Elan, M&A
PolyMedix Provides Business Update and Reports Fourth Quarter 2012 Financial Results
Yahoo/GlobeNewsWire
Wednesday, March 6, 2013 - 9:45am
tags:
PolyMedix, earnings
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Yahoo/BusinessWire
Wednesday, March 6, 2013 - 9:44am
tags:
Santarus, type 2 diabetes, Cycloset, VeroScience
Bristol-Myers might just make a big deal, WSJ says
Fierce Pharma
Tuesday, March 5, 2013 - 12:01pm
tags:
Bristol-Myers Squibb, M&A, Biogen Idec, Shire
Amgen Benefits From Affymax Recall
Seeking Alpha
Tuesday, March 5, 2013 - 11:58am
tags:
Amgen, Affymax, recalls, Omontys, Takeda, kidney disease
Can Myriad Genetics Survive the Supreme Court?
Motley Fool
Tuesday, March 5, 2013 - 11:56am
tags:
Myriad Genetics, Supreme Court, Bracanalysis
A Look At 3 Obesity Stocks
Seeking Alpha
Tuesday, March 5, 2013 - 11:52am
tags:
obesity, EnteroMedics, Vivus, Arena Pharmaceuticals
Sarepta Is Undervalued Even Without Eteplirsen Accelerated Approval
TheStreet.com
Tuesday, March 5, 2013 - 11:51am
tags:
Sarepta, eteplirsen
Sequenom Earnings: An Early Look
Motley Fool
Tuesday, March 5, 2013 - 11:46am
tags:
earnings, Sequenom
Isis Ready To Break Out Ahead Of Conference, Myriad Catalysts This Year
Seeking Alpha
Tuesday, March 5, 2013 - 11:27am
tags:
Isis Pharmaceuticals
White House urges Congress: "let FDA spend user fees"
Pharma Times, UK
Tuesday, March 5, 2013 - 11:26am
tags:
FDA, biosimilars

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.